CDK4/6 INHIBITOR
Clinical trials for CDK4/6 INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new CDK4/6 INHIBITOR trials appear
Sign up with your email to follow new studies for CDK4/6 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill combo aims to halt brain tumor growth
Disease control Not yet recruitingThis early-stage trial tests two oral drugs, IN10018 and dalpiciclib, in 24 adults with progressive meningiomas (brain tumors that have grown despite prior treatment). The study focuses on safety and finding the right dose, while also checking if the combination can shrink tumors…
Matched conditions: CDK4/6 INHIBITOR
Phase: PHASE1 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 22, 2026 11:58 UTC
-
Could a simple questionnaire replace some hospital visits for breast cancer patients?
Knowledge-focused Not yet recruitingThis study is testing a questionnaire to find out which breast cancer patients can safely skip some hospital visits during their treatment. The goal is to see if the questionnaire matches what doctors find during in-person exams. If successful, this could reduce hospital trips an…
Matched conditions: CDK4/6 INHIBITOR
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:09 UTC